Phase II study of concurrent and adjuvant chemotherapy with intensity modulated radiation therapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) plus bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer (NPC) RTOG 0615 : Preliminary toxicity report Meeting Abstract
| Authors: | Lee, N.; Zhang, Q.; Kim, J.; Garden, A. S.; Mechalakos, J.; Hu, K.; Le, Q.; Glisson, B. S.; Chan, A. T.; Pfister, D. G. |
| Abstract Title: | Phase II study of concurrent and adjuvant chemotherapy with intensity modulated radiation therapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) plus bevacizumab (BV) for locally or regionally advanced nasopharyngeal cancer (NPC) RTOG 0615 : Preliminary toxicity report |
| Meeting Title: | 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Keywords: | preliminary toxicity report |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 78 |
| Issue: | 3 Suppl.1 |
| Meeting Dates: | 2010 Oct 31-Nov 4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2010-11-01 |
| Start Page: | S103 |
| End Page: | S104 |
| Language: | English |
| ACCESSION: | BIOSIS:PREV201100141489 |
| PROVIDER: | biosis |
| PUBMED: | 21309134 |
| DOI: | 10.1016/j.ijrobp.2010.07.269 |
| Notes: | --- - Meeting Abstract: 221 - 52nd Annual Meeting of the American-Society-For-Radiation-Oncology - San Diego, CA, USA - October 31 -November 04, 2010 - Amer Soc Radiation Oncol - "Source: Biosis" |
